840 Participants Needed

Technology-Enabled Skin Cancer Screening for Stem Cell Transplant Survivors

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: City of Hope Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial studies the impact of educating stem cell transplant patients and their doctors on early detection of skin cancer. Patients receive information on how to check their skin and periodic reminders, while doctors get training and tools to better identify suspicious spots. The goal is to catch skin cancer early when it is easier to treat.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

Is technology-enabled skin cancer screening safe for stem cell transplant survivors?

The research does not provide specific safety data for technology-enabled skin cancer screening, but it focuses on increasing screening rates and education, which are generally safe practices.12345

How does the Technology-Enabled Skin Cancer Screening treatment differ from other treatments for skin cancer in stem cell transplant survivors?

This treatment is unique because it focuses on increasing skin cancer screening rates through educational interventions for both patients and their doctors, rather than directly treating the cancer itself. It aims to identify and overcome barriers to regular screening, which is crucial for early detection and reducing cancer-related health issues in stem cell transplant survivors.13567

What data supports the effectiveness of this treatment for skin cancer screening in stem cell transplant survivors?

The study 'Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors' suggests that using technology to activate both patients and physicians can increase skin cancer screening rates among transplant survivors, who are at high risk for skin cancer. Additionally, the 'Skin cancer screening after solid organ transplantation' study highlights the importance of having a screening policy and education to improve adherence to screening practices, which can be relevant to the effectiveness of the treatment in increasing screening rates.158910

Who Is on the Research Team?

SH

Saro H Armenian

Principal Investigator

City of Hope Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This trial is for stem cell transplant survivors who are 2-5 years post-transplant, can read and write in English or Spanish, have seen a primary care provider recently or plan to within a year, and can receive text messages. Those with active cancer or acute illness that limits participation cannot join.

Inclusion Criteria

Have a mobile phone with the ability to receive text messages
I had a stem cell transplant at City of Hope.
Have seen a primary care provider (PCP) in the previous 12 m (expected > 95% of all eligible) or planning to do so in next 12 m
See 3 more

Exclusion Criteria

I do not have an active blood cancer or severe illness that would prevent me from participating in the study.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a study packet on skin cancer and text messages every 3 weeks for 9 months. Physicians may receive additional educational materials and tools.

9 months

Follow-up

Participants are monitored for changes in skin cancer screening practices and health promotion activities.

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Computer-Assisted Intervention
  • Dermatoscope
  • Educational Intervention
  • Educational Intervention (Physician)
  • Questionnaire Administration
  • Text Message
Trial Overview The TEACH Study tests a 12-month program aimed at early skin cancer detection in stem cell transplant survivors. It includes education for both patients and doctors, questionnaires, computer tools, dermatoscopes for skin examination, and follow-up via text messaging.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Group III (PAE, physician, dermatoscope)Experimental Treatment6 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit. Physicians also receive a free dermatoscope with instructions for uploading images of suspect lesions and attend a 30-minute online course comprising additional descriptions of dermoscopic images for skin cancers and "mimickers" common in hematopoietic stem cell transplantation patients, along with clear instructions for using a dermatoscope and steps to integrate dermoscopy into their practice.
Group II: Group II (PAE, physician)Experimental Treatment4 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months. Participants' physician receives a letter that describes the educational intervention and encourages them to do a skin examination at next patient visit.
Group III: Group I (PAE)Experimental Treatment3 Interventions
Participants receive a study packet on skin cancer. Participants also receive text messages once every 3 weeks for 9 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

City of Hope Medical Center

Lead Sponsor

Trials
614
Recruited
1,924,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Citations

Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH). [2021]
Skin cancer screening after solid organ transplantation: Survey of practices in Canada. [2023]
Skin cancer prevention education for kidney transplant recipients: a systematic evaluation of Internet sites. [2022]
Educational outcomes regarding skin cancer in organ transplant recipients: Randomized intervention of intensive vs standard education. [2015]
Assessing individual patients' knowledge of benign versus malignant skin lesions in the dermatology clinic population. [2022]
Comparison of Patient and Provider Practices between Bone Marrow and Solid Organ Transplantation Programs for Patient Education on Increased Risk of Skin Cancer. [2023]
One-Year Review of the SCREEN (Skin Cancer Post-Transplant) Clinic. [2022]
Skin Cancer Early Detection Practices among Adult Survivors of Childhood Cancer Treated with Radiation. [2020]
Use of a brief educational video administered by a portable video device to improve skin cancer knowledge in the outpatient transplant population. [2022]
Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection among individuals diagnosed with melanoma. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security